Agilon Health AGL Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: Agilon Health’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
- Agilon Health (AGL) reported proceeds from maturities, prepayments and calls of debt securities, available-for-sale of $48.47M in Q4 2025.
- How has Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale changed year-over-year?
- Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale decreased by 6.3% year-over-year, from $51.73M to $48.47M.
- What is the long-term trend for Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
- Over 2 years (2023 to 2025), Agilon Health's proceeds from maturities, prepayments and calls of debt securities, available-for-sale has grown at a 8.7% compound annual growth rate (CAGR), from $164.04M to $193.87M.
- What does proceeds from maturities, prepayments and calls of debt securities, available-for-sale mean?
- This measures cash inflows resulting from the natural maturity or early redemption of debt securities held in the investment portfolio. It indicates the recurring cash generation from the company's fixed-income investment strategy.